Likewise, a decrease in neurogenesis in the DG during aging may contribute to age-dependent cognitive decline, tau hyperphosphorylation and a risk of Alzheimer’s disease [44,45,46,47]. This evidence concerns the gene MAPT and Alzheimer disease.